The largest database of trusted experimental protocols
> Disorders > Anatomical Abnormality > Colonic Polyps

Colonic Polyps

Colonic Polyps are abnormal growths that develop on the inner lining of the colon or rectum.
They can vary in size, shape, and number, and while many are benign, some may develop into colorectal cancer over time if left untreated.
Identifying and removing colonic polyps is an important step in preventing colorectal cancer, the third most common cancer worldwide.
Understanding the characteristics, risk factors, and best practices for detecting and managing colonic polyps is crucial for healthcare providers and researchers in this field.

Most cited protocols related to «Colonic Polyps»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2018
APOB protein, human BMPR1A protein, human Cardiovascular Diseases Colonic Polyps Genes Genetic Diversity Genome, Human Hypercholesterolemia LDLR protein, human MLH1 protein, human MSH6 protein, human MUTYH protein, human Nucleotides Patient Acceptance of Health Care PCSK9 protein, human Pharmaceutical Preparations PMS2 protein, human Point-of-Care Systems POLD1 protein, human Reproduction SMAD4 protein, human

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2010
Asian Persons Colonic Polyps Colonoscopy Ethnicity Females Gender Hispanics Intestines Males Patients Physicians Polyps
We embedded a survey within a genomic medicine implementation study conducted as part of the eMERGE consortium. The parent study provided genomic sequencing of 109 medically actionable genes to 3,037 individuals in an effort to identify previously undetected inherited disease risks and assess the medical and psychosocial implications of genomic risk screening[7 ]. Although genomic sequencing was conducted under a research protocol, an associated clinical report was placed in participants’ electronic medical record. Clinically actionable results were communicated in-person to participants by a genetic counselor but variants of uncertain significance were not returned. Participants were informed about these and other potential clinical implications of study results at the time of consent.
The study sample consisted of individuals with one of two phenotypes—documented colon polyps and hyperlipidemia. To create the sample, the Mayo Clinic biobank, a genetic biobank with approximately 55,000 samples,[8 (link)] along with a smaller Vascular Disease Biorepository,[9 (link)] were screened to identify 5,106 eligible participants exhibiting one or both of the phenotypes of interest. Eligible participants were mailed a study packet containing a letter of invitation,a study brochure, a “Frequently Asked Questions” document, and an informed consent document. These items described the risks and benefits of participating in the study, including information about the potential results that participants might receive, and discussed potential consequences for family members. The aim of these documents was to present common elements of an in-person genetic counseling session. Those electing to participate in the study returned a signed consent form in a postage-paid envelop. Optional pre-test genetic counseling was available at no cost and was described several times in the study invitation materials, along with a phone number to call to schedule an appointment with a genetic counselor.
Publication 2018
Colonic Polyps Counselors Family Member Genes Genes, vif Genome Hereditary Diseases Hyperlipidemia Parent Phenotype Reproduction Vascular Diseases
In an ongoing screening colonoscopy-based cross-sectional study, known as the Case Transdisciplinary Research in Cancer and Energetics [TREC] Colon Polyps Study, we have prospectively collected data (lifestyle risk factors and fasting blood samples) from 1,259 individuals from January 2006 to March 2009. Patients were recruited from University Hospitals Case Medical Center and affiliated endoscopy centers and were eligible if they were scheduled for a routine screening colonoscopy; informed consent was obtained from each subject prior to their participation in the study. Individuals were determined to be ineligible if they had a prior diagnosis of cancer, colon polyps or inflammatory bowel disease (including Crohn’s disease or ulcerative colitis), or were under the age of 30. After signing the informed consent, each participant was asked to complete a phone survey, fill out questionnaires and donate a blood sample. The phone survey was based on the lifestyle risk factor questionnaire (RFQ) developed by the NCI colon cancer family registry group (http://epi.grants.cancer.gov/CFR/about_questionnaires.html). The questionnaires each participant filled out included the Arizona Food Frequency Questionnaire, Physical Activity and Meat Preparation questionnaire. All three questionnaires were developed and validated by the Arizona Diet, Behavior and Quality of Life Assessment Center (http://azcc.arizona.edu/research/shared-services/bmss). A research nurse obtained the blood sample just prior to their colonoscopy and immediately refrigerated it. Blood processing was done the same day as collection. All tubes were spun for 15 minutes at 600g and aliquots of plasma, serum and concentrated buffy coat were prepared and frozen at −80°C. Incident cases were defined by histological confirmation of adenomatous polyps after their colonoscopy. We excluded individuals diagnosed with cancer. Patients who had a negative colonoscopy were classified as controls. The response rate was 64.9% among individuals eligible to participate in the study. The distribution of age, gender and race did not differ between individuals who participated and those who elected not to participate (p>0.05). This study has been approved by the University Hospitals Case Medical Center Institutional Review Board.
From these 1,259 participants who completed all the study procedures by the time of this analysis, 1 was excluded because of rectal cancer diagnosis. From these remaining 1,258, 2 were excluded because they were missing info on history of diabetes, 3 were missing information on diabetes medication use in the past 2 years and 31 had unreadable values of insulin/glucose. Thus, the final study population for this analysis included 1,222 individuals; 902 without adenomas (73.8%) and 320 with adenomas (26.2%).
Publication 2011
Adenoma Adenomatous Polyps BLOOD Cancer of Colon Colonic Polyps Colonoscopy Crohn Disease Diabetes Mellitus Diagnosis Diet Endoscopy, Gastrointestinal Ethics Committees, Research Food Freezing Gender Glucose Inflammatory Bowel Diseases Insulin Malignant Neoplasms Meat Nurses Patients Pharmaceutical Preparations Plasma Polyps Rectal Cancer Serum Ulcerative Colitis
Participants identified from the Sangre Por Salud Biobank were invited for an in-person visit with the research coordinator during which the study was introduced and the informed consent process ensued. The decision to implement an in-person visit (as opposed to consenting by mail) included the low response that MPHC historically receives with mail correspondence, the uniqueness of genetic research in this setting and foreseen challenges with low literacy and poor reading comprehension of written documents. To this point, across the Sangre Por Salud Biobank from which all Arizona RAVE participants were recruited, fewer than 50% of individuals completed high school. [8 (link)] The in-person visit allowed the research coordinator to meet face-to-face with each potential participant, provide a structured educational background on genes and genetic testing using an audiovisual format, explain the study in detail, and answer participant’s questions in real time.
Participants were eligible if they remained active as a Sangre Por Salud Biobank participant and MPHC patient and had dyslipidemia (defined as LDL-cholesterol >140 mg/dL, HDL-cholesterol <40 mg/dL, or triglycerides >150 mg/dL) and/or evidence of colon polyps (any histology). Potentially eligible individuals were sent an invitation letter and/or received a call from the research coordinator. The letter invited participants to call the research coordinator for more information or allowed participants to decline by returning a “Not Interested” notice in a pre-paid return envelope. In addition to mailing out letters, the research coordinator made phone calls to potentially eligible participants to explain the project and, if interested, schedule an in-person visit.
During the in-person visit and prior to meeting with the research coordinator, a narrated slide show was used to explain basic concepts related to inheritance and possible risks and benefits of genetic testing. The term “actionable” was also explained. This ~15 minute educational narrative presentation was delivered on a laptop/tablet in the individual’s language of choice; it was developed specifically for the Arizona RAVE study population to prepare potential participants for the informed consent discussion (available upon request). The intention of the narrated presentation was to facilitate a more transparent and patient-centered approach to informed decision making regarding participation [10 (link)].
The RAVE Study offered participants the option of receiving only the results related to familial hypercholesterolemia and colorectal cancer (i.e., “primary results” of a subset of all the sequenced genes) or to receive all of the genetic testing results that were deemed medically actionable, even if not related to the eligibility phenotypes in this study (“secondary results”). Informed consent was obtained by a bilingual/bicultural research coordinator in the participants preferred language. Those participants who provided informed consent went on to complete a survey to evaluate the following broad constructs: a) understanding of potential genomic results, b) concerns about having genomic data in the electronic health record, c) worries about future employability or insurance coverage, d) views regarding sharing genomic results with family members and others, e) perceived challenges and barriers to sharing genomic results with others, f) intent to pursue medical evaluation or counseling in response to genomic results, and g) confidence about their decision to pursue genomic testing. Assistance with survey completion was provided as needed. Participants were reimbursed $50 for their time.
Publication 2018
Cholesterol, beta-Lipoprotein Colonic Polyps Colorectal Carcinoma Dyslipidemias Eligibility Determination Face Family Member Genes Genetic Background Genome High Density Lipoprotein Cholesterol Hyperlipoproteinemia Type IIa Patient Participation Patients Pattern, Inheritance Phenotype Tablet Triglycerides

Most recents protocols related to «Colonic Polyps»

The collected data was analysed using the IBM SPSS for Windows, version 20.0 (IBM, Armonk, NY, USA). The distribution of all variables was verified for normality using the Kolmogorov–Smirnoff test, with verification using skewness and kurtosis. Continuous and categorical variables were expressed as means with standard deviation (SD) and frequency as percentages (%), respectively. The Jonckheere–Terpstra test and the Mantel–Haenszel Chi-square test were used to evaluate trends in p values for continuous and categorical data, respectively. Analysis of variance (ANOVA) was used to test for a mean difference in the distribution of the dietary intake and specific food groups across the E-DII quartiles. A multiple covariate-adjusted logistic regression model was applied to generate the OR and corresponding 95% confidence interval (95% CI) for the risk of CRC and colonic polyps according to E-DII quartile. The multivariable model was adjusted for BMI (for all subjects), age, sex, and smoking status. A linear test for trend was conducted by including the median value of each E-DII quartile as a continuous variable in the regression model. Stratified analyses were carried out in subgroups of factors that have been linked with CRC risk, including sex, age groups, smoking status, and anthropometric indices. The lowest E-DII quartile (the most anti-inflammatory diet) was the reference group for all models. All statistical tests were run with an alpha level of 0.05.
Full text: Click here
Publication 2023
Age Groups Anti-Inflammatory Agents Colonic Polyps Diet Food

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Adenomatous Polyps Adult Cecum Colon, Ascending Colonic Polyps Colonoscopy Colorectal Carcinoma Consultant Endoscopy Gastroenterologist Inflammatory Bowel Diseases Patients Polyps Sigmoid Colon Specialists Tertiary Healthcare
Colonoscopy examinations were performed with the Olympus EVIS V1 video endoscopy system and the ENDO-AID CADe artificial intelligence device. All colonoscopy examinations were performed under anesthesiologist supervision under short-term intravenous isolated propofol sedation. The dose of medicine was determined by the anesthesiologist.
Bowel cleanliness was assessed by an endoscopist using the BPPS scale. Six subjects were excluded from the study due to poor bowel preparation (0–1 in any of the three bowel sections).
The time of evacuation of the instrument from the cecum for each performed colonoscopy was not less than 7 min and was monitored by the endoscopist’s assistant.
Any detected polyp was described in the colonoscopy report according to the Paris [21 (link)] and NICE [22 (link)] classifications, and the location of the polyp in the colon and its size were specified.
The biopsied or ablated polyp was sent for morphological examination. If a polyp was found, at least two pieces from the lesion were taken before polypectomy; in the event that the removed polyp disappeared in the colon fluid, the tissue was available for morphological evaluation.
The examination begins by inspecting the anal canal and the rectum, performing an examination in retroversion to evaluate the mucosa above the “Z” line and evaluate the condition of internal hemorrhoidal nodes. When the mucosa of the anal canal is viewed in retroversion, the endoscope is advanced proximally into the sigmoid, descending, transverse, and ascending the colon until the dome of the cecum is reached. By moving the endoscope proximally into the colon, the residual contents are evacuated from the colon. A mandatory requirement for a high-quality colonoscopy examination is photo-documentation of the opening of the appendix. If technically possible, a retroversion examination was also performed in the cecum.
The right side of the colon was examined twice, returning distally from the cecum to the transverse colon, inspecting the mucosa in NBI mode, and again proximal to the cecum.
In order to detect flat polyps of the right colon, after evacuating the instrument from the caecum for the second time, staining of the mucosa with methylene blue solution was performed.
Further inspection of the mucosa of the colon was performed by gradually evacuating the endoscope, also carefully inspecting the mucosa behind the folds.
Full text: Click here
Publication 2023
Anal Canal Anesthesiologist Cecum Colon Colonic Polyps Colonoscopy Endometriosis Endoscopes Endoscopy, Gastrointestinal Intestines Juniperus oxycedrus Medical Devices Methylene Blue Mucous Membrane Perisylvian syndrome Pharmaceutical Preparations Physical Examination Polyps Propofol Rectum Sedatives Sigmoid Colon Supervision Tissues Transverse Colon
The training and validation datasets used for the proposed system were obtained from the PolypsSet dataset [22 (link)] and Chang Gung Memorial Hospital (Table 1). In total, 3750 low-quality images and 2500 high-quality images were selected by experienced colonoscopists from the experimental datasets. The low-quality images included blurred images and images that contained folds, fecal matter, and opaque water. High-quality images were defined as images with clear and well-distended colon lumen and with no fecal residue or opaque fluid. Each image had a resolution of 640 × 480 pixels and was a TIF file. Among the low-quality images, the number of blurred images and the number of images containing folds, fecal matter, and opaque fluid were 2500 and 1250, respectively. In addition, the number of high-quality images containing polyps and the number of those containing no polyps were 1250 and 1250, respectively. The test dataset was derived from six videos (Table 2) that had been obtained for this study from Linkou Chang Gung Memorial Hospital. Each video was in MKV format, lasted approximately 15 min, and displayed 30 frames per second. The colonoscope model was CF-H290L/I, which featured a 170° angle of view, a forward-viewing direction of view, and a depth of field of 5–100 mm. After the images were de-identified and all of the non-intestinal information was cropped from the images, the images had a resolution of 720 × 960 pixels. After the deletion of the first 3–10 min portion of each video, which showed the insertion of the colonoscope into the cecum, the remaining footage was employed for polyp detection and identification at 3 frames per second. Among the dynamic images obtained from the videos, the number of blurred images and the number of images containing folds, fecal matter, and opaque water were 8716 and 1967, respectively, and the numbers of high-quality normal images and polyp images were 399 and 50, respectively. All of the videos featured one polyp, except for Case #1, which featured two polyps (Table 3). Polyp detection was performed using a CNN model for classification, and the training dataset comprised 612 images from the CVC-ClinicDB dataset and 500 images from the PolypsSet dataset (Table 4).
Figure 2 shows the architecture of the proposed intraprocedure alert system, which provides blurred image detection, foreign body detection, and polyp detection. Blurred image detection is used to identify blurred images that have occurred due to camera shaking, to the colonoscope being withdrawn too rapidly, or to the lens being stained with fecal matter or opaque fluid. The presence of a colon fold and fecal matter or methods for fluid detection are used to indicate abnormal protrusions that may be haustral folds and creases or fecal residue. Finally, polyp detection is used to identify polyp protrusions in the colon lumen [3 (link)]. All of these functions are provided by the proposed CNN deep learning model. Figure 3 and Table 5 present the proposed CNN deep learning model architecture for the detection of blurred images, fecal matter, opaque water, and colon folds. Figure 4 and Table 6 present the polyp detection architecture for feature extraction and the bounding box transformation layer for the result output. Notably, polyp detection was performed on images from the six videos to verify the effectiveness of the system in identifying false alerts after low-quality images were excluded.
The size of each input image was measured in terms of the width (W) × Height (H) × filter number (N). All of the images were adjusted to fit the specification of the CNN deep learning model. We employed convolution, batch normalization, a rectified linear unit, and maximum pooling operations to conduct feature extraction [3 (link)]. Table 5 and Table 6 show the filters, size/stride, and output image size of each operation. A classification conversion layer was used to distinguish blurred images from non-polyp foreign body images. In addition, fully connected, softmax, and classification output layers were used for classification.
Full text: Click here
Publication 2023
Body Image Cecum Colon Colonic Polyps Colonoscopes Deletion Mutation Feces Foreign Bodies Intestines Lens, Crystalline Polyps Reading Frames
A survey was conducted in August, 2022 at 45 Korean institutions that perform pediatric colonoscopic polypectomy. Sex, age group of the pediatric endoscopic specialists, the number of years that the pediatric endoscopic specialists had performed colonoscopic polypectomy, the geographic region of the institution, the initial examination (colonoscopy or sigmoidoscopy) performed when a polyp was clinically suspected were all included in the questionnaire. We investigated the performance of a total colonoscopy if a polyp was identified in the left colon, the performance of an esophagogastroduodenoscopy (EGD) according to the number of polyps observed in the colon, the performance of EGD if five or more polyps were observed in the colon, and surveillance based on histology findings of less than five polyps in the colon.
We compared questionnaire variables across the groups based on the age of pediatric endoscopic specialists, duration of colonoscopic polypectomy practice, and geographic location of the participating institution.
Publication 2023
Age Groups Colon Colonic Polyps Colonoscopes Colonoscopy Endoscopy Esophagogastroduodenoscopy Koreans Polyps Proctosigmoidoscopy Specialists

Top products related to «Colonic Polyps»

Sourced in United States, Montenegro, China
The ApcMin/+ mice are a genetically engineered mouse model used in research. These mice carry a mutation in the Apc gene, which is involved in tumor suppression. This mutation leads to the development of multiple intestinal neoplasia (MIN) in the mice.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States, Montenegro, United Kingdom, Germany, Australia, China, Canada
C57BL/6 is a widely used inbred mouse strain. It is a robust, readily available laboratory mouse model.
Sourced in United States
EndoWorks is a digital workflow management system developed by Olympus for use in endoscopy procedures. It provides comprehensive tools for capturing, managing, and storing endoscopic images and video recordings. The core function of EndoWorks is to facilitate the efficient documentation and organization of endoscopic data to support clinical workflows.
Sourced in United States
Male athymic nude mice are laboratory animals that lack a functional thymus gland, resulting in a compromised immune system. They are commonly used in medical research and drug development due to their ability to accept transplanted tissues and cells from other species without rejection.
Sourced in United States, Japan, United Kingdom, Germany, Austria, Belgium, Denmark, China, Israel, Australia
SPSS version 21 is a statistical software package developed by IBM. It is designed for data analysis and statistical modeling. The software provides tools for data management, data analysis, and the generation of reports and visualizations.
Sourced in United States, United Kingdom, Germany, China, Japan, Canada, France, Lithuania, Spain, Belgium, Switzerland, Italy, Australia, Sweden
The MirVana miRNA Isolation Kit is a product designed for the isolation and purification of microRNA (miRNA) from various biological samples, including cells, tissues, and body fluids. The kit utilizes a specialized protocol and reagents to selectively extract and concentrate miRNA from the sample, while removing other RNA species and cellular components.
Sourced in United States
The EMR Kit is a specialized piece of laboratory equipment designed for the analysis and measurement of electromagnetic radiation. It provides essential tools and instrumentation for researchers and scientists working in fields that involve the study of electromagnetic phenomena.
Sourced in United States
The TruSeq mRNA Sample Prep Kit is a laboratory equipment product designed for the isolation and preparation of messenger RNA (mRNA) from total RNA samples. The kit provides the necessary reagents and protocols to extract, purify, and prepare mRNA for subsequent RNA-sequencing or other transcriptome analysis applications.
Sourced in United States, China, Australia, Japan, Germany, Hong Kong, Sweden, United Kingdom
The HiSeq X Ten is a high-throughput DNA sequencing system manufactured by Illumina. It is designed to deliver large-scale whole-genome sequencing data. The system utilizes Illumina's proprietary sequencing technology to provide rapid and accurate DNA sequencing capabilities.

More about "Colonic Polyps"

Colonic polyps are abnormal growths that develop on the inner lining of the colon or rectum.
They can vary in size, shape, and number, and while many are benign, some may progress into colorectal cancer over time if left untreated.
Identifying and removing these polyps is a crucial step in preventing colorectal cancer, which is the third most common cancer worldwide.
Understanding the characteristics, risk factors, and best practices for detecting and managing colonic polyps is essential for healthcare providers and researchers in this field.
ApcMin/+ mice, a commonly used animal model, have been instrumental in studying the development and progression of colonic polyps.
These mice possess a mutation in the Apc gene, which is also commonly mutated in human colorectal cancer.
Researchers may utilize techniques like fluorescence-based sorting (FBS) and C57BL/6 mouse strains to isolate and study specific cell populations from polyp samples.
Additionally, tools like the EndoWorks software and Male athymic nude mice can aid in the visualization and study of polyp growth and behavior.
Statistical analysis of polyp data is often performed using software like SPSS version 21.
Molecular techniques, such as the MirVana miRNA Isolation Kit and the TruSeq mRNA Sample Prep Kit, can be employed to investigate the genetic and epigenetic factors underlying polyp formation and progression.
For clinical applications, endoscopic mucosal resection (EMR) is a common technique used to remove and analyze colonic polyps.
Collaboration between healthcare providers and researchers is crucial to improve our understanding of colonic polyps and develop more effective strategies for their prevention and management.